<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://hdl.handle.net/20.500.12701/1846">
    <title>DSpace Собрание: The Breast is a multidisciplinary open access journal for researchers and clinicians, which focuses on translational and clinical research for the advancement of breast cancer prevention, diagnosis and treatment of all stages.</title>
    <link>http://hdl.handle.net/20.500.12701/1846</link>
    <description>The Breast is a multidisciplinary open access journal for researchers and clinicians, which focuses on translational and clinical research for the advancement of breast cancer prevention, diagnosis and treatment of all stages.</description>
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://hdl.handle.net/20.500.12701/1847" />
      </rdf:Seq>
    </items>
    <dc:date>2024-05-03T12:19:59Z</dc:date>
  </channel>
  <item rdf:about="http://hdl.handle.net/20.500.12701/1847">
    <title>Molecular breast cancer subtypes: relationship with clinicopathological characteristics, efficacy of neoadjuvant chemotherapy and survival</title>
    <link>http://hdl.handle.net/20.500.12701/1847</link>
    <description>Название: Molecular breast cancer subtypes: relationship with clinicopathological characteristics, efficacy of neoadjuvant chemotherapy and survival
Авторы: Babyshkina, N.; Malinovskaya, E.; Zavyalova, M.; Cherdyntseva, N.; Slonimskaya, E.
Краткий осмотр (реферат): Recent studies have emphasized the importance of the molec-&#xD;
ular portraits of breast cancer for use of new treatment strategies and&#xD;
prognostication of disease. The aim of this study was to evaluate the&#xD;
clinicopathological characteristics, the response to treatment and clinical&#xD;
outcomes of breast cancer patients according to molecular cancer subtype...</description>
    <dc:date>2011-03-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

